This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Delivered as a Hybrid Event 17-19 May 2022
Live In-Person Event: 17-19 May, Steigenberger Wiltcher's, BrusselsDigital Experience: All presentation recordings on-demand for 10 days from 24th May

Jacques Sivignon
Partner at Dechert LLP


Mr. Sivignon's principal activity is acting for multinational clients in complex commercial litigation, product liability, industrial risk and post-acquisition matters with a particular focus on pharmaceutical and healthcare industries. Mr. Sivignon also represents funds, investment advisers and related entities in investors’ litigation, securities and other financial disputes. His practice includes advising clients on compliance issues and working on a number of investigations dealing with corruption, fraud and violations of securities regulation.

Mr. Sivignon also acts as counsel for various state entities and multinational clients in ICC arbitrations concerning general corporate, license, construction and energy-related disputes. His practice includes the setting aside or enforcement of international arbitration awards, including attachment and tracing of assets.

Mr. Sivignon is recognized among the leading litigation lawyers in France by Best Lawyers 2022. He is recommended in Chambers Europe 2021 for his work in dispute resolution in France as well as in The Legal 500 EMEA 2021.

Prior to joining Dechert, Mr. Sivignon was a member of the International Litigation/Arbitration Department in the Paris office of another international law firm. He has also worked in the firm's Brussels and Sydney offices.

Agenda Sessions

  • New Market Trends and Commercial Litigation in the Pharmaceutical Industry